Scholarlink

<p>Vaccine-based approaches provide a sustainable method for controlling pathogens in aquaculture. Our team previously created the IPath® vaccine, a recombinant formulation with metal-chelating properties. This study aimed to evaluate the performance of IPath® in salmon vaccinated with the mandatory vaccines used commercially in Chile, and to assess their effects on the transcriptome profiles of Atlantic salmon challenged with <i>Caligus rogercresseyi</i> and co-infected with <i>Piscirickettsia salmonis</i>. Four experimental groups of Atlantic salmon were immunized: IPath®, BlueGuard® (B) + Alpha Ject LiVac® SRS® (L), B + L + IPath®, and PBS as a control. After accumulating 400 thermal units (ATUs), vaccinated salmon were exposed to a coinfection model involving 35 copepodids per fish for 25&#xa0;days, followed by an intraperitoneal infection with <i>P. salmonis</i> (1 × 10^8) for 16&#xa0;days, with mortality recorded daily. Head kidney tissue samples were collected for mRNA Illumina sequencing at 25&#xa0;days post-infection (dpi) for sea lice and at 16 dpi for <i>P. salmonis</i> infections. IPath® and B + L + IPath® showed 73.7 and 69.8% reduction in sea lice burden, respectively. Furthermore, the IPath® vaccinated group showed a delay in salmon mortality following <i>P. salmonis</i> infection compared with the other experimental groups. During sea lice infection, the B + L + IPath® group upregulated key immune-related genes, such as <i>cathelicidin</i>, <i>major histocompatibility complex class I</i>, and <i>interferon regulatory factor</i>, indicating an innate and adaptive immune response. During <i>P. salmonis</i> co-infection, the B + L group downregulated immune-related transcripts, including <i>metalloendopeptidase</i>, <i>interferon regulatory factor 7,</i> and T<i>-lymphocyte surface antigen Ly-9-like.</i> Biological processes and pathways related to stress response were highly enriched in the B + L group. Notably, the IPath® and B + L + IPath® groups triggered gene regulation associated with iron balance, such as <i>ferric chelate reductase 1</i>, in response to both pathogens. A synergy between IPath® and commercial vaccines, especially in iron regulation and immune response, offers a new approach for integrated control of <i>C. rogercresseyi</i> and <i>P. salmonis</i> in salmon farming.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Synergistic Protection of Atlantic Salmon Against Caligus Rogercresseyi and Piscirickettsia Salmonis Using IPath® and Commercial Vaccines

  • 期刊论文

  • 发表日期：

    2026年7月4日

查看全文
  • Antonio Casuso,
  • Yeny Leal,
  • Cristian Gallardo-Escárate,
  • Valentina Valenzuela-Muñoz

摘要

Vaccine-based approaches provide a sustainable method for controlling pathogens in aquaculture. Our team previously created the IPath® vaccine, a recombinant formulation with metal-chelating properties. This study aimed to evaluate the performance of IPath® in salmon vaccinated with the mandatory vaccines used commercially in Chile, and to assess their effects on the transcriptome profiles of Atlantic salmon challenged with Caligus rogercresseyi and co-infected with Piscirickettsia salmonis. Four experimental groups of Atlantic salmon were immunized: IPath®, BlueGuard® (B) + Alpha Ject LiVac® SRS® (L), B + L + IPath®, and PBS as a control. After accumulating 400 thermal units (ATUs), vaccinated salmon were exposed to a coinfection model involving 35 copepodids per fish for 25 days, followed by an intraperitoneal infection with P. salmonis (1 × 10^8) for 16 days, with mortality recorded daily. Head kidney tissue samples were collected for mRNA Illumina sequencing at 25 days post-infection (dpi) for sea lice and at 16 dpi for P. salmonis infections. IPath® and B + L + IPath® showed 73.7 and 69.8% reduction in sea lice burden, respectively. Furthermore, the IPath® vaccinated group showed a delay in salmon mortality following P. salmonis infection compared with the other experimental groups. During sea lice infection, the B + L + IPath® group upregulated key immune-related genes, such as cathelicidin, major histocompatibility complex class I, and interferon regulatory factor, indicating an innate and adaptive immune response. During P. salmonis co-infection, the B + L group downregulated immune-related transcripts, including metalloendopeptidase, interferon regulatory factor 7, and T-lymphocyte surface antigen Ly-9-like. Biological processes and pathways related to stress response were highly enriched in the B + L group. Notably, the IPath® and B + L + IPath® groups triggered gene regulation associated with iron balance, such as ferric chelate reductase 1, in response to both pathogens. A synergy between IPath® and commercial vaccines, especially in iron regulation and immune response, offers a new approach for integrated control of C. rogercresseyi and P. salmonis in salmon farming.